| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,761 |
12,803 |
$213K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,279 |
6,183 |
$188K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,812 |
1,113 |
$108K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,278 |
761 |
$107K |
| 36415 |
Collection of venous blood by venipuncture |
9,777 |
7,565 |
$104K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,454 |
2,667 |
$56K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,367 |
1,202 |
$54K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,345 |
1,255 |
$53K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,300 |
1,046 |
$51K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,264 |
4,516 |
$48K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,623 |
1,536 |
$48K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,209 |
3,255 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,532 |
758 |
$32K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,738 |
1,384 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,769 |
1,682 |
$22K |
| 80053 |
Comprehensive metabolic panel |
7,304 |
5,587 |
$20K |
| 84703 |
|
2,077 |
1,905 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
411 |
396 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,366 |
6,898 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
862 |
712 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,379 |
1,468 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,238 |
2,423 |
$14K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
865 |
772 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
347 |
344 |
$13K |
| 99215 |
Prolong outpt/office vis |
793 |
411 |
$13K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,741 |
1,423 |
$12K |
| 97161 |
|
57 |
53 |
$9K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
354 |
319 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
1,367 |
1,180 |
$9K |
| J2704 |
Injection, propofol, 10 mg |
234 |
155 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
733 |
646 |
$7K |
| 81003 |
|
1,731 |
1,505 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,135 |
1,741 |
$6K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
643 |
539 |
$5K |
| 81001 |
|
4,315 |
3,671 |
$5K |
| 0240U |
|
302 |
286 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,069 |
1,548 |
$3K |
| 87276 |
|
335 |
322 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
2,330 |
1,826 |
$3K |
| 83690 |
|
1,844 |
1,569 |
$2K |
| 84484 |
|
2,593 |
1,732 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
185 |
173 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
91 |
90 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
835 |
693 |
$2K |
| 73630 |
|
59 |
51 |
$2K |
| 87088 |
|
314 |
261 |
$2K |
| 73610 |
|
68 |
64 |
$974.07 |
| J7050 |
Infusion, normal saline solution, 250 cc |
130 |
51 |
$823.10 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
986 |
827 |
$734.33 |
| 84443 |
Thyroid stimulating hormone (TSH) |
503 |
435 |
$565.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
595 |
390 |
$553.68 |
| 73562 |
|
64 |
52 |
$537.56 |
| 82948 |
|
386 |
179 |
$491.00 |
| 83735 |
|
867 |
673 |
$393.31 |
| 74018 |
|
14 |
13 |
$371.30 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$278.02 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
100 |
81 |
$196.89 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
79 |
26 |
$151.35 |
| 97597 |
|
38 |
12 |
$103.61 |
| 73110 |
|
12 |
12 |
$81.31 |
| 87077 |
|
125 |
103 |
$60.86 |
| 84134 |
|
25 |
25 |
$40.52 |
| 83880 |
|
300 |
210 |
$29.13 |
| 85730 |
|
1,087 |
848 |
$25.60 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
287 |
278 |
$21.24 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
48 |
35 |
$0.00 |
| 85379 |
|
41 |
38 |
$0.00 |
| 87070 |
|
151 |
146 |
$0.00 |
| 81000 |
|
26 |
15 |
$0.00 |
| 83605 |
|
16 |
14 |
$0.00 |
| 36000 |
|
43 |
38 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
26 |
$0.00 |
| 82553 |
|
72 |
54 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$0.00 |
| 85610 |
|
1,315 |
1,014 |
$0.00 |
| 87186 |
|
98 |
77 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
47 |
43 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
104 |
93 |
$0.00 |
| 87275 |
|
335 |
322 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
54 |
48 |
$0.00 |